Correlation Between OncoCyte Corp and Exagen
Can any of the company-specific risk be diversified away by investing in both OncoCyte Corp and Exagen at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining OncoCyte Corp and Exagen into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between OncoCyte Corp and Exagen Inc, you can compare the effects of market volatilities on OncoCyte Corp and Exagen and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in OncoCyte Corp with a short position of Exagen. Check out your portfolio center. Please also check ongoing floating volatility patterns of OncoCyte Corp and Exagen.
Diversification Opportunities for OncoCyte Corp and Exagen
-0.43 | Correlation Coefficient |
Very good diversification
The 3 months correlation between OncoCyte and Exagen is -0.43. Overlapping area represents the amount of risk that can be diversified away by holding OncoCyte Corp and Exagen Inc in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Exagen Inc and OncoCyte Corp is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on OncoCyte Corp are associated (or correlated) with Exagen. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Exagen Inc has no effect on the direction of OncoCyte Corp i.e., OncoCyte Corp and Exagen go up and down completely randomly.
Pair Corralation between OncoCyte Corp and Exagen
Considering the 90-day investment horizon OncoCyte Corp is expected to generate 0.59 times more return on investment than Exagen. However, OncoCyte Corp is 1.7 times less risky than Exagen. It trades about 0.12 of its potential returns per unit of risk. Exagen Inc is currently generating about 0.02 per unit of risk. If you would invest 245.00 in OncoCyte Corp on December 29, 2024 and sell it today you would earn a total of 77.00 from holding OncoCyte Corp or generate 31.43% return on investment over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Against |
Strength | Very Weak |
Accuracy | 100.0% |
Values | Daily Returns |
OncoCyte Corp vs. Exagen Inc
Performance |
Timeline |
OncoCyte Corp |
Exagen Inc |
OncoCyte Corp and Exagen Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with OncoCyte Corp and Exagen
The main advantage of trading using opposite OncoCyte Corp and Exagen positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if OncoCyte Corp position performs unexpectedly, Exagen can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Exagen will offset losses from the drop in Exagen's long position.OncoCyte Corp vs. Burning Rock Biotech | OncoCyte Corp vs. Neuronetics | OncoCyte Corp vs. DarioHealth Corp | OncoCyte Corp vs. Sera Prognostics |
Exagen vs. Fonar | Exagen vs. Burning Rock Biotech | Exagen vs. Sera Prognostics | Exagen vs. Castle Biosciences |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Bollinger Bands module to use Bollinger Bands indicator to analyze target price for a given investing horizon.
Other Complementary Tools
Portfolio Manager State of the art Portfolio Manager to monitor and improve performance of your invested capital | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Share Portfolio Track or share privately all of your investments from the convenience of any device | |
Commodity Channel Use Commodity Channel Index to analyze current equity momentum | |
Theme Ratings Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance |